Industry News
GeneWorks develops DNA barcoding tech
South Australia's GeneWorks has developed a DNA barcoding security technology compatible with existing forensic laboratory instruments. [ + ]
GTG gets CE Mark for breast cancer test
Genetic Technologies (ASX:GTG) has won European CE Mark approval for BREVAGen, its DNA test for increased breast cancer risk. [ + ]
New bat virus could hold key to Hendra virus
Australian scientists have discovered a new virus in bats that could help shed light on how Hendra and Nipah viruses cause disease and death in animals and humans. [ + ]
Recall costs drag down Cochlear FY12 profit
Cochlear Limited (ASX:COH) has reported a 68% slump in FY12 profit to $56.8 million due to hefty costs associated with the voluntary recall of its Nucleus Cl500 implants. [ + ]
Universal Biosensors slashes 1H loss in half
Universal Biosensors (ASX:UBI) more than halved its losses for the first half of 2012, on the back of a 133% increase in revenue. [ + ]
Epigenetics discovery aids prostate cancer diagnosis
The discovery of a microRNA that appears to affect prostate cancer proliferation and metastasis could prove a valuable biomarker for diagnosis. [ + ]
Vic Gov listens to concern on clinical trial insurance
Cognisant of industry concern, the Victorian Managed Insurance Authority (VMIA) has chosen not to increase the insurance requirements for commercial sponsors of human clinical trials in Victoria, which was intended to take effect from 1 July 2012. [ + ]
Feature: In vino veritas
A bold sequencing project hopes to reveal the genetic basis for variation in Chardonnay grapes. And it might even lead to better wine. [ + ]
ResMed stock bounce on record quarterly profit
ResMed (ASX:RMD) shares up following 12% increase in FY12 profit, on the back of another quarter of record revenue and net income. [ + ]
New research could increase blood supplies for transfusions
A team of scientists from Albert Einstein College of Medicine in the Bronx, NY, has developed methods to increase the production of red blood cells from stem cells - a discovery that could dramatically boost the blood supply available for transfusions. [ + ]
Sirtex to triple US manufacturing capacity
Sirtex (ASX:SIR) will spend $4m over the next 18 months to expand threefold its US manufacturing capacity for SIR-Spheres doses. [ + ]
Brian McNamee to step down from CSL next July
CSL's (ASX:CSL) CEO for the last 22 years, Dr Brian McNamee, will hand the reins to successor Paul Perrault in July 2013. [ + ]
Hendra relative could help combat the deadly virus
A new benign virus related to Hendra and Nipah viruses could yield insights into what makes the latter deadly and open possibilities of new treatments or vaccines. [ + ]
Gardasil vaccine may offer protection from prostate cancer
Vaccinating young males against human papilloma virus might not only slow the spread of the virus and cervical cancer in women, but may also help protect men from prostate cancer. [ + ]
AusBiotech responds to NSW’s draft Manufacturing Industry Action Plan
AusBiotech has undertaken extensive consultation with its NSW medical technology members through an open consultation forum and private meetings and responded to the draft NSW Manufacturing Industry Action Plan. [ + ]
